Nirsevimab

ATC J06BD08 · 11 markets · 20 records

Nirsevimab 11 markets · 20 records Forms

AU 3 records · 3 strengths

  • 100 mginjectionBEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe also in US·CN·ES unknown
  • 50 mginjectionBEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe also in CN·ES unknown

Records without a stated strength · 1 BEYFORTUS

US 2 records · 1 strengths

GB 2 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 2 strengths

CN 2 records · 2 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML

    MX 1 records · 1 strengths

      Records without a stated strength · 1 BEYFORTUS

      TW 1 records · 1 strengths

        Records without a stated strength · 1 Beyfortus 100 mg/mL solution for injection、樂唯初注射劑100毫克/毫升

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          Records without a stated strength · 1 BEYFORTUS

          Side-by-side table

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.